Article
Hypermutation induced by APOBEC-1 overexpression can be eliminated.
RNA (New York, N.Y.) - 1 May 2010
Chen Zhigang, Eggerman Thomas L, Bocharov Alexander V, Baranova Irina N, Vishnyakova Tatyana G, Csako Gyorgy, Patterson Amy P
Abstract excerpt
APOBEC-1 overexpression in liver has been shown to effectively reduce apoB-100 levels. However, nonspecific hypermutation and liver tumor formation potentially related to hypermutation in transgenic animals compromise its potential use for gene therapy. In studying apoB mRNA editing regulation, we found that the core editing auxiliary factor ACF dose-dependently increases APOBEC-1 nonspecific hypermutation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
